Bluerock Homes Trust, Inc.
BHM NYSE Real Estate Investment Trusts Financials FY2021βFY2025
Last close Β· Oct 23, 2026
$8.05
0.6%What Bluerock Homes Trust, Inc. does
No business description yet.
- Legal name
- Bluerock Homes Trust, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001104659-26-021568
0001903382
Revenue and margins
Bluerock Homes Trust, Inc. had $68.7M of revenue in fiscal 2025, up 36.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $10.4M in fiscal 2025, 15.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Bluerock Homes Trust, Inc. returned $1.5M to shareholders in fiscal 2025, 15% of free cash flow. The diluted share count rose 0.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Bluerock Homes Trust, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $129M | $78.4M | $80.2M | $115M | $170M |
| Debt incl. finance leases | $63.0M | $98.2M | $96.7M | $374M | $428M |
| Net debt / EBITDA | β6.5x | 2.2x | β | β | β |
| Debt / equity | 0.4x | 0.6x | 0.7x | 2.7x | 3.3x |
| Total assets | $541M | $659M | $672M | $967M | $1.2B |
| Total liabilities | $79.5M | $167M | $193M | $398M | $463M |
| Shareholders' equity | $151M | $160M | $147M | $139M | $129M |
| Net debt (β = net cash) | β$66.4M | $19.8M | $16.5M | $259M | $259M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 4 / 7 | 3 / 7 | 4 / 7 |
| Accruals ratio | 4.5% | β0.7% | β4.5% | β2.6% | β5.7% |
| Altman Z'' | β | β | β | β | β |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $14.6M | $34.1M | $41.1M | $50.2M | $68.7M |
| Operating income | $0.4M | β$9.9M | β | β | β |
| Interest expense | β | β | $13.1M | $18.1M | $24.0M |
| Pretax income | $0.9M | β$6.2M | β$15.9M | β$12.1M | β$31.0M |
| Income tax | β | β | β | $0.0M | $1.6M |
| Net income | $34.3M | β$1.0M | β$15.8M | β$12.1M | β$32.6M |
| Net income to common | $34.3M | β$1.0M | β$4.5M | β$4.2M | β$11.5M |
| Diluted EPS | $8.93 | β$0.26 | β$1.30 | β$1.10 | β$3.02 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | |||||
| Cash from operations | $9.8M | $3.5M | $13.9M | $9.1M | $27.8M |
| Capital expenditure | $1.7M | $18.6M | $9.5M | $9.3M | $17.4M |
| Free cash flow | $8.1M | β$15.2M | $4.4M | β$0.3M | $10.4M |
| Depreciation and amortization | $9.8M | $18.8M | $19.3M | $21.6M | $31.7M |
| Dividends paid | β | β | β | $3.9M | $1.5M |
| Dividends and buybacks | β | β | β | $3.9M | $1.5M |
| Balance sheet | |||||
| Cash and short-term investments | $129M | $78.4M | $80.2M | $115M | $170M |
| Total debt | $63.0M | $98.2M | $96.7M | $374M | $428M |
| Intangible assets | β | β | β | $2.7M | β |
| Total assets | $541M | $659M | $672M | $967M | $1.2B |
| Total liabilities | $79.5M | $167M | $193M | $398M | $463M |
| Shareholders' equity | $151M | $160M | $147M | $139M | $129M |
| Margins | |||||
| Operating margin | 2.7% | β29.1% | β | β | β |
| EBITDA margin | 69.8% | 25.8% | β | β | β |
| Net margin | 234.6% | β2.9% | β38.4% | β24.1% | β47.4% |
| FCF margin | 55.4% | β44.4% | 10.6% | β0.5% | 15.1% |
| Returns | |||||
| Return on capital | 0.4% | β4.4% | β | β | β |
| Return on equity | 22.8% | β0.6% | β10.3% | β8.4% | β24.3% |
| Return on assets | 6.3% | β0.2% | β2.4% | β1.5% | β3.1% |
| Return on tangible equity | 22.8% | β0.6% | β3.1% | β3.1% | β8.9% |
| Growth | |||||
| Revenue growth | β | 133.4% | 20.4% | 22.2% | 36.9% |
| Net income growth | β | β102.9% | β | β | β |
| EPS growth | β | β102.9% | β | β | β |
| FCF growth | β | β286.9% | β | β105.8% | β |
| Share count change | β | 0.0% | 0.0% | 0.3% | 0.9% |
| Financial health | |||||
| Net debt / EBITDA | β6.5x | 2.2x | β | β | β |
| Debt / equity | 0.4x | 0.6x | 0.7x | 2.7x | 3.3x |
| Capital allocation | |||||
| Capex / revenue | 11.6% | 54.6% | 23.2% | 18.5% | 25.3% |
| Payouts / FCF | β | β | β | β | 14.5% |
| Quality scores | |||||
| Piotroski F-score | β | 4.0 | 4.0 | 3.0 | 4.0 |
| Accruals ratio | 4.5% | β0.7% | β4.5% | β2.6% | β5.7% |
Source: SEC EDGAR XBRL filings (CIK 0001903382). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.